Daniel Spinosa
YOU?
Author Swipe
View article: Diagnosis and treatment of a mixed ovarian malignant germ cell tumor with glioblastoma transformation
Diagnosis and treatment of a mixed ovarian malignant germ cell tumor with glioblastoma transformation Open
The case presented here discusses the rare presentation of mixed malignant germ cell tumor of the ovary with concurrent glioblastoma transformation and gliomatosis peritonei. While long-term outcomes cannot be concluded based on this case,…
View article: PR023/#503 Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability
PR023/#503 Evaluation of the combination lenvatinib and pembrolizumab in endometrial cancer; a real world multi-institutional review of practice patterns, efficacy and tolerability Open
Introduction Keynote-775 defined the SOC for MMRp recurrent EC. AEs with recommended dosing of lenvatinib/pembrolizumab led to dose reductions in 66.5% of patients. Real world prescription patterns vary significantly from clinical trial. W…
View article: 23 Post-operative care for patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): is there room to de-escalate post-operative care?
23 Post-operative care for patients undergoing hyperthermic intraperitoneal chemotherapy (HIPEC): is there room to de-escalate post-operative care? Open
Hyperthermic intraperitoneal chemotherapy (HIPEC) has been integrated into the upfront care of ovarian cancer patients since Van Driel et al. published their Phase III data demonstrating significantly improved overall survival with the add…
View article: Prevention of venous thromboembolism in patients with cancer
Prevention of venous thromboembolism in patients with cancer Open
Venous thromboembolism (VTE) is a major cause of both morbidity and mortality in patients with cancer. Venous thromboembolism, which includes both deep vein thrombosis and pulmonary embolism, affects a sizable portion of patients with mali…
View article: Endometrial cancer: molecular classification and future treatments
Endometrial cancer: molecular classification and future treatments Open
The treatment for endometrial cancer is rapidly evolving with the development of molecular analysis and novel strategies. Surgical resection, cytotoxic chemotherapy, endocrine or hormonal treatment, and radiation have been the staples of t…
View article: Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia
Molecular Classification to Prognosticate Response in Medically Managed Endometrial Cancers and Endometrial Intraepithelial Neoplasia Open
Background: The aim of this study was to evaluate whether molecular classification prognosticates treatment response in women with endometrial cancers and endometrial intraepithelial neoplasia (EIN) treated with levonorgestrel intrauterine…
View article: SARS-CoV-2 vaccination in gynecologic oncology
SARS-CoV-2 vaccination in gynecologic oncology Open
European Journal of Gynaecological Oncology (EJGO) is an international, peer-reviewed, open access journal, which is currently indexed in SCIE, etc. It covers many aspects of gynaecologic oncology topics, including Cervical Cancer, Fallopi…
View article: 443 Participant demographics and disparities in ovarian cancer clinical trials
443 Participant demographics and disparities in ovarian cancer clinical trials Open
Background Clinical trials comprise the cornerstone of advancing care for patients with ovarian cancer. Diverse populations of trial participants are essential to ensuring generalizability of results. To date, no prior study has aggregated…